Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naim Shehadeh

Showing results (91-100 of 104) with videos related to

Pageof 11
Sort By:
Circulation Research|May 17, 2003
Genetically determined heterogeneity in hemoglobin scavenging and susceptibility to diabetic cardiovascular diseaseRabea Asleh, Stuart Marsh, Mark Shilkrut, et al.
Diabetes Care|June 9, 2022
Once-Weekly Exenatide in Youth With Type 2 DiabetesWilliam V Tamborlane, Raafat Bishai, David Geller, et al.
International Journal of Molecular Sciences|December 5, 2019
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Alpha-1 Antitrypsin (AAT) (Glassia<sup>®</sup>) in the Treatment of Recent-Onset Type 1 DiabetesYael Lebenthal, Avivit Brener, Eli Hershkovitz, et al.
Diabetes|September 28, 2004
Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2: patient characteristics and initial response to sulfonylurea therapyJørn V Sagen, Helge Raeder, Eba Hathout, et al.
The New England Journal of Medicine|April 30, 2019
Liraglutide in Children and Adolescents with Type 2 DiabetesWilliam V Tamborlane, Margarita Barrientos-Pérez, Udi Fainberg, et al.
Cardiovascular Diabetology|October 24, 2020
Worldwide inertia to the use of cardiorenal protective glucose-lowering drugs (SGLT2i and GLP-1 RA) in high-risk patients with type 2 diabetesGuntram Schernthaner, Naim Shehadeh, Alexander S Ametov, et al.
Current Medical Research and Opinion|April 22, 2011
Hypoglycaemia in sulphonylurea-treated subjects with type 2 diabetes undergoing Ramadan fasting: a five-country observational studyS R Aravind, Khaled Al Tayeb, Shaiful Bahari Ismail, et al.
Diabetes Care|October 29, 2021
Prediction of Personal Glycemic Responses to Food for Individuals With Type 1 Diabetes Through Integration of Clinical and Microbial DataSmadar Shilo, Anastasia Godneva, Marianna Rachmiel, et al.
Diabetes Care|January 19, 2022
The Gut Microbiome of Adults With Type 1 Diabetes and Its Association With the Host Glycemic ControlSmadar Shilo, Anastasia Godneva, Marianna Rachmiel, et al.
Diabetes Research and Clinical Practice|March 3, 2019
The characteristics and pattern of care for the type 2 diabetes mellitus population in the MENA region during Ramadan: An international prospective study (DAR-MENA T2DM)Mohamed Hassanein, Fatheya F Al Awadi, Khaled El Sayed El Hadidy, et al.
Pageof 11

Showing results (91-100 of 104) with videos related to

Sort By:
Pageof 11
Circulation Research|May 17, 2003
Genetically determined heterogeneity in hemoglobin scavenging and susceptibility to diabetic cardiovascular diseaseRabea Asleh, Stuart Marsh, Mark Shilkrut, et al.
Diabetes Care|June 9, 2022
Once-Weekly Exenatide in Youth With Type 2 DiabetesWilliam V Tamborlane, Raafat Bishai, David Geller, et al.
International Journal of Molecular Sciences|December 5, 2019
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Alpha-1 Antitrypsin (AAT) (Glassia<sup>®</sup>) in the Treatment of Recent-Onset Type 1 DiabetesYael Lebenthal, Avivit Brener, Eli Hershkovitz, et al.
Diabetes|September 28, 2004
Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2: patient characteristics and initial response to sulfonylurea therapyJørn V Sagen, Helge Raeder, Eba Hathout, et al.
The New England Journal of Medicine|April 30, 2019
Liraglutide in Children and Adolescents with Type 2 DiabetesWilliam V Tamborlane, Margarita Barrientos-Pérez, Udi Fainberg, et al.
Cardiovascular Diabetology|October 24, 2020
Worldwide inertia to the use of cardiorenal protective glucose-lowering drugs (SGLT2i and GLP-1 RA) in high-risk patients with type 2 diabetesGuntram Schernthaner, Naim Shehadeh, Alexander S Ametov, et al.
Current Medical Research and Opinion|April 22, 2011
Hypoglycaemia in sulphonylurea-treated subjects with type 2 diabetes undergoing Ramadan fasting: a five-country observational studyS R Aravind, Khaled Al Tayeb, Shaiful Bahari Ismail, et al.
Diabetes Care|October 29, 2021
Prediction of Personal Glycemic Responses to Food for Individuals With Type 1 Diabetes Through Integration of Clinical and Microbial DataSmadar Shilo, Anastasia Godneva, Marianna Rachmiel, et al.
Diabetes Care|January 19, 2022
The Gut Microbiome of Adults With Type 1 Diabetes and Its Association With the Host Glycemic ControlSmadar Shilo, Anastasia Godneva, Marianna Rachmiel, et al.
Diabetes Research and Clinical Practice|March 3, 2019
The characteristics and pattern of care for the type 2 diabetes mellitus population in the MENA region during Ramadan: An international prospective study (DAR-MENA T2DM)Mohamed Hassanein, Fatheya F Al Awadi, Khaled El Sayed El Hadidy, et al.
Pageof 11